In Reply: Diabetic retinopathy: Screening, prevention, and treatment
We thank Ashley Lim for the comments on our review article.[1][1] We are pleased that readers are interested in our review and appreciate the opportunity to discuss any concerns raised in the letter. We agree that new therapies such as glucagon-like peptide-1 (GLP-1) receptor agonists and sodium-
Authors
- David D. Chong (ORCID: https://orcid.org/0000-0002-4247-2263)
- Rishi P. Singh (ORCID: https://orcid.org/0000-0001-5859-8162)
- Nikhil Das (ORCID: https://orcid.org/0000-0003-1557-3592)
Institutions
- Cleveland Clinic (US)
- Cleveland Clinic Lerner College of Medicine (US)
- Cleveland Clinic Florida (US)
- University School (US)
- Cleveland Eye Clinic (US)
- Martin Health System (US)
- Case Western Reserve University (US)
Publication Details
- Journal
- Cleveland Clinic Journal of Medicine
- Published
- 2024-12-01
- DOI
- https://doi.org/10.3949/ccjm.91c.12002
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00